Telemedicine for type 2 diabetes during COVID-19 pandemic: experience from a tertiary diabetes center

被引:2
作者
Angelino, Silvia [1 ]
Caruso, Paola [2 ]
Longo, Miriam [2 ,3 ]
Barrasso, Mariluce [2 ]
Castaldo, Filomena [2 ]
Pontillo, Alessandro [2 ]
Arena, Stefania [1 ]
Palmieri, Annarita [1 ]
Bellastella, Giuseppe [2 ,3 ]
Maiorino, Maria I. [2 ,3 ]
Esposito, Katherine [2 ,3 ]
机构
[1] Univ Campania Luigi Vanvitelli, Dept Expt Med, PhD Program Traslat Med, Naples, Italy
[2] Univ Campania Luigi Vanvitelli, Unit Endocrinol & Metab Dis, Piazza L Miraglia, I-80138 Naples, Italy
[3] Univ Campania Luigi Vanvitelli, Dept Adv Med & Surg Sci, Naples, Italy
来源
MINERVA ENDOCRINOLOGY | 2025年 / 50卷 / 02期
关键词
Telemedicine; Diabetes mellitus; type; 2; Glycemic control; COVID-19; HEALTH-CARE; INTERVENTION; METAANALYSIS; MELLITUS; OUTCOMES;
D O I
10.23736/S2724-6507.23.04096-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Telemedicine was largely employed during COVID-19 pandemic to guarantee continuity of care in a period of dramatic reduction of face-to-face visits. The aim of this study was to describe the clinical characteristics of a cohort of patients with type 2 diabetes followed by tele-visits and to evaluate the changes in the glyco-metabolic control during a 12-month follow-up. METHODS: This retrospective observational study included 136 adults aged >18 years with at least three tele-visits over a 12-month follow-up period, in a Diabetes Center of the Southern Italy, from April 2020 to March 2022. Data related to glycemic and lipid profile, therapy, presence of micro or macrovascular complications, and other clinical features were extracted at three time points, at first visit (T0), after 6 months (T1) and after 12 months (T2). RESULTS: Mean diabetes duration and median HbA1c values were 11.6 years and 7.0%, respectively. Thirty-eight participants (27.9%) presented macro- or microvascular complications. Glycemic control remained stable over time, without clinically significant changes of HbA1c (T0 vs. T1 vs. T2, median [IQR], 7.0 [6.2-7.3], 6.6 [6.0-7.5], 6.9 [6.2-7.5], P=0.095) and fasting glucose. Lipid profile slightly improved, although without significant clinical change. Glucose lowering therapy was modified in 84 patients (61.8%) and remained unchanged in 52 patients (38.2%) during the follow-up. No participant in the study developed any complications during the 12-month follow-up. CONCLUSIONS: People with type 2 diabetes followed by telemedicine were adults with fair glucose control generally free from chronic complications, whose diabetes control did not worsen during a 12-month follow-up.
引用
收藏
页码:163 / 171
页数:9
相关论文
共 35 条
[1]  
[Anonymous], 2015, IDF DIABETES ATLAS, V7th
[2]  
[Anonymous], 1978, Law 833/78. Establishment of the National Health Service
[3]  
[Anonymous], 2010, TELEMEDICINE OPPORTU, DOI DOI 10.4258/HIR.2012.18.2.153
[4]  
Associazione Medici Diabetologi-Societa italiana di diabetologia (SID), 2018, Standard italiani per la cura del diabete mellito 2018
[5]   Factors related to high and low levels of drug adherence according to patients with type 2 diabetes [J].
Borgsteede, Sander D. ;
Westerman, Marjan J. ;
Kok, Irene L. ;
Meeuse, Joke C. ;
de Vries, Theo P. G. M. ;
Hugtenburg, Jacqueline G. .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (05) :779-787
[6]   Type 2 diabetes patients' and providers' differing perspectives on medication nonadherence: a qualitative meta-synthesis [J].
Brundisini, Francesca ;
Vanstone, Meredith ;
Hulan, Danielle ;
DeJean, Deirdre ;
Giacomini, Mita .
BMC HEALTH SERVICES RESEARCH, 2015, 15
[7]   Telemedicine for the management of diabetic patients in a high-complexity Latin American hospital [J].
Casas, Luz Angela ;
Alarcon, Juliana ;
Urbano, Alejandra ;
Pena-Zarate, Evelyn E. ;
Sangiovanni, Saveria ;
Libreros-Pena, Laura ;
Escobar, Maria Fernanda .
BMC HEALTH SERVICES RESEARCH, 2023, 23 (01)
[8]   Type 2 diabetes [J].
Chatterjee, Sudesna ;
Khunti, Kamlesh ;
Davies, Melanie J. .
LANCET, 2017, 389 (10085) :2239-2251
[9]   Impact of COVID-19 on routine care for chronic diseases: A global survey of views from healthcare professionals [J].
Chudasama, Yogini, V ;
Gillies, Clare L. ;
Zaccardi, Francesco ;
Coles, Briana ;
Davies, Melanie J. ;
Seidu, Samuel ;
Khunti, Kamlesh .
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (05) :965-967
[10]   Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience [J].
de Kreutzenberg, Saula Vigili .
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2022, 29 (04) :319-326